Ind-Swift Laboratories Ltd Performance
Day's High
₹100.65₹101.5552 Week's Low
52 Week's High
₹81.85₹186
| Returns % | |
| 1 Month Return | -16.26 % |
| 3 Month Return | -26.1 % |
| 1 Year Return | + 7.76 % |
| Market Stats | |
| Previous Close | ₹102.71 |
| Open | ₹100.65 |
| Volume | 26.97K |
| Upper Circuit | - |
| Lower Circuit | - |
| Market Cap | ₹606.88Cr |
Ind-Swift Laboratories Ltd Key Statistics
| P/E Ratio | 1.59 |
| PEG Ratio | 0.03 |
| Market Cap | ₹606.88 Cr |
| P/B Ratio | 0.63 |
| EPS | 71.33 |
| Dividend Yield | 0 |
| Sector | Pharmaceuticals |
| ROE | 18.99 |
Ind-Swift Laboratories Ltd Peer Comparison
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
|---|---|---|---|---|---|---|
| NA | ₹606.88 Cr | 55.68% | 0.51 | ₹421 Cr | ₹1,280 Cr | |
| NA | ₹44.02 Cr | 1.53% | 0.58 | NA | NA | |
| NA | ₹260.52 Cr | 273.93% | 0.58 | -₹12 Cr | ₹15 Cr | |
| NA | ₹286.75 Cr | 122.28% | 0.66 | ₹5 Cr | ₹155 Cr | |
| NA | ₹15,763.63 Cr | 26.32% | 0.51 | NA | NA |
About Ind-Swift Laboratories Ltd
Share Price: ₹100.65 per share as on 22 Nov, 2024 04:01 PM
Market Capitalisation: ₹606.88Cr as of today
Revenue: ₹11.96Cr as on September 2024 (Q3 24)
Net Profit: ₹0.40Cr as on September 2024 (Q3 24)
Listing date: 02 Jul, 1997
Chairperson Name: N R Munjal
| Organisation | Ind-Swift Laboratories Ltd |
| Headquarters | Chandigarh |
| Industry | Pharmaceuticals |
| E-voting on shares | Click here to vote |
Key events for Ind-Swift Laboratories Ltd
Ind-Swift Laboratories Ltd Share Price Surges by 29% - 02 Jul, 2024
The share price of Ind-Swift Laboratories Limited has surged higher by 29% over the last month, bringing the annual gain to a sharp 51%. The company's lower P/S ratio may indicate potential risks placing downward pressure on the share price.
Ind-Swift Laboratories Ltd Stock Up 296% in Five Years - 29 Jun, 2024
Ind-Swift Laboratories' stock has grown by 32% CAGR over five years, with a 30% increase in the last quarter. The company moved from loss to profitability during this period.
Ind-Swift Laboratories to Raise Funds Through Issuance of Instruments - 25 Jun, 2024
Ind-Swift Laboratories reported a consolidated net profit of Rs 238.82 crore in Q4 FY24, compared to a net loss of Rs 25.12 crore in Q4 FY23. The company's board will meet on June 27, 2024, to raise funds through the issuance of one or more instruments via various modes.
Insights on Ind-Swift Laboratories Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTRetail Holding Up
Retail Investor have increased holdings from 56.21% to 56.41% in Sep 2024 quarter
NO EFFECTAgainst Peers
In the last 3 years, Sun Pharmaceuticals Industries Ltd has given 128.6% return, outperforming this stock by 87.6%
- NO EFFECT
Against Peers
In the last 1 year, Divis Laboratories Ltd has given 62.6% return, outperforming this stock by 54.9%
- NO EFFECT
Promoter Holding Unchanged
Promoters holdings remained unchanged at 42.00% of holdings in Sep 2024 quarter
NEGATIVE IMPACTFII Holding Down
Foreign Institutions have decreased holdings from 0.85% to 0.65% in Sep 2024 quarter
- NEGATIVE IMPACT
Price Dip
In the last 1 month, INDSWFTLAB stock has moved down by -16.3%
- NEGATIVE IMPACT
Profit Down
Netprofit is down for the last 3 quarters, 352.64 Cr → 0.41 Cr (in ₹), with an average decrease of 78.1% per quarter
- NEGATIVE IMPACT
Revenue Fall
Revenue is down for the last 3 quarters, 805.18 Cr → 24.96 Cr (in ₹), with an average decrease of 69.1% per quarter
Ind-Swift Laboratories Ltd Financials
Ind-Swift Laboratories Ltd Shareholding Pattern
| Investors | Holdings % | FY Quarter | 3M change |
|---|---|---|---|
| Promoter Holdings | 42% | 0.00 | |
| Foreign Institutions | 0.65% | ||
| Mutual Funds | 0% | 0.00 | |
| Retail Investors | 56.41% | 0.35 | |
| Others | 0.94% | 0.00 |
Ind-Swift Laboratories Ltd Key Indicators
Ind-Swift Laboratories Ltd Valuation
Ind-Swift Laboratories Ltd in the last 5 years
Lowest (-1795.00x)
December 8, 2022
Today (1.59x)
November 22, 2024
Industry (54.77x)
November 22, 2024
Highest (64.97x)
July 19, 2021
Ind-Swift Laboratories Ltd Earnings and Dividends
Ind-Swift Laboratories Ltd Earnings Results
Ind-Swift Laboratories Ltd’s net profit fell -98.7% since last year same period to ₹0.41Cr in the Q2 2024-2025. On a quarterly growth basis, Ind-Swift Laboratories Ltd has generated -56.38% fall in its net profits since last 3-months.
Read More about Earnings Results
Ind-Swift Laboratories Ltd Technicals Summary
Bearish
Neutral
Bullish
Ind-Swift Laboratories Ltd is currently in a Bearish trading position according to technical analysis indicators.
FAQs on Ind-Swift Laboratories Ltd
- Get a PAN card.
- Open a Demat account.
- Open a Trading account.
- Link your Demat account to your Trading account.
- Fund your Trading account.
- Place an order to buy Ind-Swift Laboratories Ltd shares.
Ind-Swift Laboratories Ltd (INDSWFTLAB) share price today is ₹100.65
Ind-Swift Laboratories Ltd is listed on NSE
Ind-Swift Laboratories Ltd is listed on BSE
- Today’s highest price of Ind-Swift Laboratories Ltd is ₹101.55.
- Today’s lowest price of Ind-Swift Laboratories Ltd is ₹100.65.
PE Ratio of Ind-Swift Laboratories Ltd is 1.59
PE ratio = Ind-Swift Laboratories Ltd Market price per share / Ind-Swift Laboratories Ltd Earnings per share
Today’s traded volume of Ind-Swift Laboratories Ltd(INDSWFTLAB) is 26.97K.
Today’s market capitalisation of Ind-Swift Laboratories Ltd(INDSWFTLAB) is ₹606.88Cr.
| Ind-Swift Laboratories Ltd(INDSWFTLAB | Price |
|---|---|
52 Week High | ₹186 |
52 Week Low | ₹81.85 |
Ind-Swift Laboratories Ltd(INDSWFTLAB) share price is ₹100.65. It is down -45.89% from its 52 Week High price of ₹186
Ind-Swift Laboratories Ltd(INDSWFTLAB) share price is ₹100.65. It is up 22.97% from its 52 Week Low price of ₹81.85
| Ind-Swift Laboratories Ltd(INDSWFTLAB | Returns |
|---|---|
1 Day Returns | -2.06% |
1 Month Returns | -16.26% |
3 Month Returns | -26.1% |
1 Year Returns | 7.76% |